<prompt> Levosimendan is approved inHea failureKidney failureLiver failureEndocrine crisis  <response>: Levosimendan is a calcium sensitizer -- it increases the sensitivity of the hea to calcium, thus increasing cardiac contractility without a rise in intracellular calcium.Has been approved for use in acute cardiac failure in EuropeKatzung 13e pg: 220 